Colorectal Mucinous Adenocarcinoma: The Clinicopathologic Features and Significance of p16 and p53 Expression
Authors:
- Alfred King-Yin LamAlfred King-Yin Lam
- Kate OngKOKate Ong
- Yik-Hong HoYHYik-Hong Ho
- 1 September 2006
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 49 (9) , 1275-1283
Abstract
This study was designed to examine the clinicopathologic features and p53 and p16 expressions in colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma. The clinicopathologic features of 36 patients with colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma were analyzed and compared with 228 patients with colorectal adenocarcinomas. The p53 and p16 expressions in the colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma were studied by immunohistochemistry. Colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma accounted for 14 percent of colorectal cancer. The median age at presentation was 67 years. Family history of colorectal cancer in their first-degree relatives was seen in 14 percent of these patients. Fifty-six percent of the carcinomas were located in the proximal colorectum, most commonly in the transverse colon. Two patients had ulcerative colitis. Compared with the usual colorectal adenocarcinoma, colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma was found more often in proximal colorectum (P = 0.002), larger (P = 0.05), and in advanced stages (P = 0.018). Forty-four percent (n = 16) of the colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma showed p53 expression. All the patients with colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma with a positive family history of colorectal adenocarcinoma had tumors that showed p53 expression (P = 0.012). Seventy-eight percent (n = 28) of the tumors showed p16 expression. The median survival of the patients with these tumors was 23 months. The survival of these patients with colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma was poorer if the lesions were of advanced stages (P = 0.023) or with family history of colorectal cancer (P = 0.0015). Also, patients with colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma that did not express p16 and p53 had better survival than other patients (P = 0.04). Colorectal mucinous adenocarcinoma and colorectal signet-ring cell carcinoma had distinctive clinicopathologic features. Tumor staging, family history of colorectal cancer, and status of p53 and p16 expressions might predict prognosis in these patients.Keywords
This publication has 17 references indexed in Scilit:
- A 10-Year Outcomes Evaluation of Mucinous and Signet-Ring Cell Carcinoma of the Colon and RectumDiseases of the Colon & Rectum, 2005
- Prognostic significance of mucinous component in colorectal carcinomaTechniques in Coloproctology, 2004
- Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survivalLaboratory Investigation, 2004
- The p16INK4a-RB pathway : molecular link between cellular senescence and tumor suppressionThe Journal of Medical Investigation, 2004
- Incidence and Survival of Mucinous Adenocarcinoma of the Colorectum: A Population-Based Study From an Asian CountryDiseases of the Colon & Rectum, 2004
- Nodal staging of colorectal carcinomas and sentinel nodesJournal of Clinical Pathology, 2003
- Clinicopathological characteristics of mucinous carcinoma of the colon and rectumJournal of Surgical Oncology, 2000
- Is mucinous carcinoma of the colorectum a distinct genetic entity?British Journal of Cancer, 1995
- Mucinous carcinoma—Just another colon cancer?Diseases of the Colon & Rectum, 1993
- p53 Mutations in Human CancersScience, 1991